alaa wafa

diabetes dm diabetes mellitus diabetes management thyroid disorders glycemic control endocrine management hypoglycemia insulinoma hemodialysis dpp-4 inhibitors pitutary gland hyperprolactinemia chronic renal failure crf dkd type 2 diabetes liver thyrotoxicosis carbimazol risk fsctors statin brain-gut axis brain guidelines antidiabetic drugs updates insulin clinical aspects management. lactation geriatric elderly diabetic acth teststerone erectile dysfunction prolactin fsh esrd estrogen lh hypothalamus cortisl adrenal gland sexual dysfunction end stage renal disease impotence adrenal sex hormone abnormal menstruation diminshed libido erectile dysfuntion gonades endocrinal manifestation genetics of dm diabetic nephropathy genetic kidney genetics dianetic nephropathy diabetic kidney disease prevention oral antidiabetic ada pathogensis aace slt-2 inhibitors sulphonyurea treatment of hyperglycemia incretind glinides fibrosis insulin resistance sulphonylurea sliymarin liver function pioglitazone hepatocellular carcinoma hcc diabetes and liver hyperglycemia clinical aspects of thyroid diseases examination radioactive iodine clinical aspects of thyroid disorders\ inspection palpation malignancy thyroiditis hypothyroidism antithyroid goiter thyroid thyroalex propylethiouracil cholestasis hepatitis liver cell failure thyrocil antithyroid treatment and liver diabetes ramadan hhs dka risk ramadan lipid profile dyslipidemia infarction stroke cholesterol iha brain as an endocrine organ hormon brain as endocrine organ glycemia leptin glp-1 ischemia foot ulcer vasculopathy peripheral neuropathy diabetic foot peripheral arterial sisease pad amputation macrovscular diseases pathogenesis of diabetes c peptide and diabetes type 1 diabetes cvs cpeptide aminoa acids dysglysemia glucose yariability diabetes management in hemodialysid hba1c glucose dialysis dysglycemia and ckd diabete mellitus